Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Net Margin (2016 - 2025)

Veracyte's Net Margin history spans 14 years, with the latest figure at 29.29% for Q4 2025.

  • For Q4 2025, Net Margin rose 2500.0% year-over-year to 29.29%; the TTM value through Dec 2025 reached 12.84%, up 743.0%, while the annual FY2025 figure was 12.84%, 743.0% up from the prior year.
  • Net Margin for Q4 2025 was 29.29% at Veracyte, up from 14.51% in the prior quarter.
  • Across five years, Net Margin topped out at 29.29% in Q4 2025 and bottomed at 114.06% in Q1 2021.
  • The 5-year median for Net Margin is 9.55% (2023), against an average of 11.57%.
  • The largest annual shift saw Net Margin plummeted -7641bps in 2021 before it surged 9272bps in 2022.
  • A 5-year view of Net Margin shows it stood at 15.55% in 2021, then soared by 69bps to 4.82% in 2022, then plummeted by -499bps to 28.88% in 2023, then soared by 115bps to 4.29% in 2024, then skyrocketed by 582bps to 29.29% in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Net Margin are 29.29% (Q4 2025), 14.51% (Q3 2025), and 0.74% (Q2 2025).